2-MABB

2-MABB
Clinical data
Other names2-(2-(Methylamino)butyl)benzofuran
ATC code
  • None
Identifiers
  • 1-(1-benzofuran-2-yl)-N-methylbutan-2-amine
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC13H17NO
Molar mass203.285 g·mol−1
3D model (JSmol)
  • CCC(CC1=CC2=CC=CC=C2O1)NC
  • InChI=1S/C13H17NO/c1-3-11(14-2)9-12-8-10-6-4-5-7-13(10)15-12/h4-8,11,14H,3,9H2,1-2H3
  • Key:YBPPNDUCEMDPJZ-UHFFFAOYSA-N

2-MABB, also known as 2-(2-(methylamino)butyl)benzofuran, is a psychoactive drug of the substituted benzofuran family.[1][2][3][4] It was encountered as a novel designer drug in Europe in 2016.[4] The drug has been made a controlled substance in Sweden, Italy, and Russia.[1][2][3]

See also

References

  1. ^ a b "2-MABB". AIPSIN Drugs (in Russian). Retrieved 3 February 2026.
  2. ^ a b "2-MABB". AIPSIN Drugs (in Russian).
  3. ^ a b Di Luca NM, Busardò FP, Pirani F, Varì MR (2020). "Evolution of Italian laws banning trafficking, use and abuse of psychotropic drugs". Annali Dell'Istituto Superiore Di Sanita. 56 (1): 76–89. doi:10.4415/ANN_20_01_12. PMID 32242539.
  4. ^ a b Annual Report on the implementation of Council Decision 2005/387/JHA. EMCDDA–Europol (Report). 2016.